Ferris RG, Hazen RJ, Roberts GB, et al. Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrob Agents Chemother. 2005; 49 (10): 4046–4051.

Huder JB, Böni J, Hatt JM, et al. Identification and Characterization of Two Closely Related Unclassifiable Endogenous Retroviruses in Pythons (Python molurus and Python curtus). J Virol. 2002; 76 (15): 7607–7615.

Jones KS, Akel S, Petrow-Sadowski C, et al. Induction of Human T Cell Leukemia Virus Type I Receptors on Quiescent Naive T Lymphocytes by TGF-1,2. The Journal of Immunology. 2005; 174: 4262-4270.

Jones KS, Nath M, Petrow-Sadowski C, et al. Similar Regulation of Cell Surface Human T-Cell Leukemia Virus Type 1 (HTLV-1) Surface Binding Proteins in Cells Highly and Poorly Transduced by HTLV-1-Pseudotyped Virions. J Virol. 2002; 76 (24): 12723–12734.

Medinas RJ, Lambert DM, Tompkins WA. C-Terminal gp40 Peptide Analogs Inhibit Feline Immunodeficiency Virus: Cell Fusion and Virus Spread. J Virol. 2002; 76 (18): 9079–9086.

Paolucci S, Baldanti F, Maga G, et al. Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication. Antimicrob Agents Chemother. 2004; 48 (12): 4611–4617.

Uckun FM, Rajamohan F, Pendergrass S, et al. Structure-Based Design and Engineering of a Nontoxic Recombinant Pokeweed Antiviral Protein with Potent Anti-Human Immunodeficiency Virus Activity.  Antimicrob Agents Chemother. 2003; 47 (3): 1052-1061.